Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Clinical trial NCT06439836 · RECRUITING
Trial details
- NCT number
- NCT06439836
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-05
- Primary completion
- 2027-06-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.